Pure Global AI
NCT05044052Enrolling by invitation

Does Inclusion of Viral Prescription Pad Resources Increase Responsiveness to Feedback About Antibiotic Prescribing in Primary Care

Do Peer-comparisons, Emphasis on Harms, and/or Inclusion of Viral Prescription Pad Resources Increase Responsiveness to Feedback About Antibiotic Prescribing in Primary Care: Protocol for Two Linked Trials With Embedded Process Evaluations (OH Trial)
Women's College HospitalClinicalTrials.govbehavioral
Study focus
Disease/Condition
Infection
Drug/Device/Intervention
Emphasis on the Choosing Wisely Viral Prescription Pad
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Women's College Hospital
Location
Toronto, Canada
Timeline & enrollment
Phase
N/A
Start date
Dec 15, 2021
End date
Dec 30, 2022
Enrollment
4000 participants
Primary outcome

Antibiotic prescribing rate

Summary

Antibiotic overuse is common and antibiotic prescribing contributes to rising rates of
 antimicrobial resistance. Primary care physicians prescribe the majority of all antibiotics
 and there is large inter-physician variability in prescribing that cannot be explained by
 differences in patient populations.
 
 In Ontario, audit and feedback (A&F) is routinely offered to primary care providers from a
 variety of sources. Ontario Health - an agency created by the Government of Ontario -
 provides A&F via email to physicians who voluntarily sign up for their MyPractice reports.
 These are multi-topic reports with aggregated (physician-level) data. As of November 2021,
 the MyPractice reports for family physicians will include data on antibiotic prescribing. To
 date, less than half of Ontario family physicians have signed up for the MyPractice reports
 from Ontario Health.
 
 For this study, the investigators will conduct a trial to investigate the effect of adding
 viral prescription pad resources to family physician A&F received through a MyPractice:
 Primary Care report. This evaluation provides an opportunity to determine if the addition of
 this resource to an A&F intervention increases changes to antibiotic prescribing.

ICD-10 classifications
Bacterial infection, unspecifiedBacterial, viral and other infectious agentsInfection following immunizationOther infectious diseasesViral infection, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05044052
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05044052 through Pure Global AI's free database. This phase not specified trial is sponsored by Women's College Hospital and is currently Enrolling by invitation. The study focuses on Infection. Target enrollment is 4000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.